DiaMedica Therapeutics Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-18. The offering totals $750K, of which $750K was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| James Parsons | Director | Mississauga, A6 |
| David J Wambeke | Executive Officer | Minneapolis, MN |
| Charles P Semba | Director | Minneapolis, MN |
| Lorianne Masuoka | Executive Officer | Minneapolis, MN |
| Daniel T O'Connor | Director | Minneapolis, MN |
| Scott Kellen | Executive Officer | Minneapolis, MN |
| Richard R Kuntz | Director | Minneapolis, MN |
| Michael R Giuffre | Director | Minneapolis, MN |
| Tanya N Lewis | Director | Minneapolis, MN |
| Rick Pauls | Director | Minneapolis, MN |
| Rick Pauls | Executive Officer | Minneapolis, MN |
| James T Parsons | Director | Minneapolis, MN |
| Richard Michael Kuntz | Director | Minneapolis, MN |
| R. Michael Giuffre | Director | Minneapolis, MN |
| Richard D Pilnik | Director | Minneapolis, MN |
| Dominic Cundari | Executive Officer | Minneapolis, MN |
| Julie Daves | Executive Officer | Minneapolis, MN |
| Kirsten Gruis | Executive Officer | Minneapolis, MN |
| Richard P Kuntz | Director | Minneapolis, MN |
| Amy L Burroughs | Director | MINNEAPOLIS, MN |
| Harry W Alcorn Jr. | Executive Officer | MINNEAPOLIS, MN |
| Sydney Gilman | Executive Officer | MINNEAPOLIS, MN |
| Richard Pilnik | Director | Houston, TX |
| Paul Papi | Executive Officer | Minneapolis, MN |
| Zhenyu Jerry Xiao | Director | Minneapolis, MN |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-07-25 | D | $30.1M | $30.1M |
| 2024-07-02 | D | $11.8M | $11.8M |
| 2023-06-27 | D | $37.5M | $37.5M |
| 2021-10-06 | D | $30.0M | $30.0M |
| 2018-04-17 | D | $344K | $201K |